Kindstar Globalgene Technology, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KDGTF research report →
About the company
Kindstar Globalgene Technology, Inc. delivers advanced, specialized diagnostic testing solutions to hospitals throughout China. These sophisticated services are designed to assist clinical specialist physicians across a range of medical fields, including hematological oncology, rare genetic conditions, obstetrics and gynecology, neurological disorders, infectious diseases, and solid tumor analysis, among others.
- CEO
- Shiang Huang
- IPO
- 2021
- Employees
- 3,052
- HQ
- Wuhan, CN
Get TickerSpark's AI analysis on KDGTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $675.13M
- P/E
- -19.59
- PEG
- -0.21
- P/S
- 0.87
- P/B
- 0.31
- EV/EBITDA
- -13.40
- Div Yield
- 10.11%
- Gross Margin
- 45.55%
- Op Margin
- -9.54%
- Net Margin
- -4.37%
- ROE
- -1.56%
- ROIC
- -2.98%
- 52W High
- $0.71
- 52W Low
- $0.64
- 50D MA
- $0.68
- 200D MA
- $0.68
- Beta
- 0.00
- Avg Volume
- 0
No earnings-call transcripts are available for KDGTF yet.
- Free Float
- 0.0%
- Shares Outstanding
- 988.04M
- Float Shares
- 0
Our KDGTF coverage
Recent articles, reports, and earnings notes.
No research on KDGTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KDGTF report →